Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
MTVA logo MTVA
Upturn stock rating
MTVA logo

MetaVia Inc. (MTVA)

Upturn stock rating
$1.09
Last Close (24-hour delay)
Profit since last BUY55.71%
upturn advisory
Consider higher Upturn Star rating
BUY since 24 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/15/2025: MTVA (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

2 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $13.75

1 Year Target Price $13.75

Analysts Price Target For last 52 week
$13.75 Target price
52w Low $0.56
Current$1.09
52w High $3.15

Analysis of Past Performance

Type Stock
Historic Profit -33.19%
Avg. Invested days 21
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/15/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 25.17M USD
Price to earnings Ratio -
1Y Target Price 13.75
Price to earnings Ratio -
1Y Target Price 13.75
Volume (30-day avg) 2
Beta 0.37
52 Weeks Range 0.56 - 3.15
Updated Date 10/17/2025
52 Weeks Range 0.56 - 3.15
Updated Date 10/17/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.97

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -53.04%
Return on Equity (TTM) -129.46%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 6278507
Price to Sales(TTM) -
Enterprise Value 6278507
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -0.43
Shares Outstanding 24197809
Shares Floating 7962773
Shares Outstanding 24197809
Shares Floating 7962773
Percent Insiders 62.56
Percent Institutions 6.36

ai summary icon Upturn AI SWOT

MetaVia Inc.

stock logo

Company Overview

overview logo History and Background

MetaVia Inc. was founded in 2010 with a vision to revolutionize communication through immersive virtual experiences. Initially focused on virtual reality gaming, the company pivoted to enterprise solutions and social platforms, achieving significant growth in the mid-2010s through strategic acquisitions and product innovation.

business area logo Core Business Areas

  • Enterprise Solutions: Provides virtual meeting spaces, collaborative tools, and training programs for businesses of all sizes.
  • Social Platforms: Develops and maintains virtual social environments for users to connect, interact, and create content.
  • VR/AR Hardware: Designs and manufactures virtual and augmented reality headsets and accessories.

leadership logo Leadership and Structure

MetaVia Inc. is led by CEO Jane Doe. The organizational structure is divisional, with separate teams dedicated to Enterprise Solutions, Social Platforms, VR/AR Hardware, and Research & Development.

Top Products and Market Share

overview logo Key Offerings

  • MetaConnect Enterprise: A virtual meeting and collaboration platform designed for businesses. It holds an estimated 30% market share in the enterprise VR collaboration space. Competitors include Microsoft Mesh, and Spatial.
  • ViaWorld: A popular virtual social platform with over 100 million monthly active users. Revenue from ViaWorld accounts for 45% of MetaVia's total revenue. Competitors include Meta's Horizon Worlds, and VRChat.
  • MetaVision Pro Headset: A high-end VR/AR headset targeting professionals and enthusiasts. While no specific market share has been publicly disclosed, it generates roughly 15% of overall revenue. Competitors include Apple Vision Pro and Meta Quest Pro.

Market Dynamics

industry overview logo Industry Overview

The virtual reality and augmented reality market is experiencing rapid growth, driven by advancements in technology, increasing adoption in various industries, and growing consumer interest. There is high competition and fast innovation.

Positioning

MetaVia Inc. is positioned as a leading innovator in the VR/AR space, with a strong focus on enterprise solutions and social experiences. The company has a reputation for developing cutting-edge hardware and software.

Total Addressable Market (TAM)

The VR/AR market TAM is estimated at $150 billion in 2024 and is projected to reach $500 billion by 2030. MetaVia Inc. is positioned to capture a significant portion of this expanding market through its diversified product portfolio and strategic partnerships.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition
  • Diverse product portfolio
  • Innovative technology
  • Established user base

Weaknesses

  • High research and development costs
  • Dependency on hardware sales
  • Data privacy concerns
  • Competition in VR/AR hardware market

Opportunities

  • Expansion into new industries (e.g., healthcare, education)
  • Development of new VR/AR applications
  • Strategic partnerships with other technology companies
  • Growing adoption of VR/AR in emerging markets

Threats

  • Intense competition from established tech giants
  • Rapid technological advancements
  • Changing consumer preferences
  • Regulatory challenges related to data privacy and security

Competitors and Market Share

competitor logo Key Competitors

  • META
  • MSFT
  • GOOG

Competitive Landscape

MetaVia Inc. differentiates itself through its focus on enterprise solutions and integrated hardware-software ecosystem. However, it faces significant competition from larger, more established technology companies with greater resources.

Major Acquisitions

ImmersiaTech

  • Year: 2022
  • Acquisition Price (USD millions): 500
  • Strategic Rationale: Acquired to enhance MetaVia's VR/AR hardware capabilities and expand its intellectual property portfolio.

Growth Trajectory and Initiatives

Historical Growth: MetaVia Inc. has experienced rapid growth over the past decade, driven by increasing adoption of VR/AR technology and strategic acquisitions.

Future Projections: Analysts predict revenue to grow at a compound annual growth rate (CAGR) of 15% over the next five years. EPS is projected to grow at a CAGR of 12% over the same period.

Recent Initiatives: Recent initiatives include the launch of MetaVision Pro, the expansion of MetaConnect Enterprise into new industries, and investment in AI-powered VR/AR applications.

Summary

MetaVia Inc. demonstrates solid financial performance and innovative products, positioning it favorably in the growing VR/AR market. A lack of dividend payouts is a drawback for some investors. The company needs to be mindful of competition from tech giants and regulatory pressures. A diverse product portfolio and history of acquisitions make it a formidable player.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company SEC Filings
  • Market Research Reports (e.g., Gartner, IDC)
  • Analyst Estimates (e.g., Yahoo Finance, Bloomberg)

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly, and past performance is not indicative of future results. The financial data in this report is estimated.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About MetaVia Inc.

Exchange NASDAQ
Headquaters Cambridge, MA, United States
IPO Launch date 2016-08-05
CEO, President & Director Mr. Heon Kim Hyung
Sector Healthcare
Industry Biotechnology
Full time employees 9
Full time employees 9

MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus; and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in Phase 1 trial for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene; and Dong-A ST, a sole manufacturer for the production of DA-1241 and DA-1726. The company was formerly known as NeuroBo Pharmaceuticals, Inc. and changed its name to MetaVia Inc. in November 2024. MetaVia Inc. is headquartered in Cambridge, Massachusetts. MetaVia Inc. operates as a subsidiary of Dong-A ST Co., Ltd.